Literature DB >> 36149666

Functional Abdominal Cramping Pain: Expert Practical Guidance.

Stefan Müller-Lissner1, Viola Andresen2, Maura Corsetti3,4, Luis Bustos Fernández5, Sylvie Forestier6, Fabio Pace7, Miguel A Valdovinos8.   

Abstract

Functional abdominal cramping pain (FACP) is a common complaint, which may present either on its own or in association with a functional gastrointestinal disorder. It is likely caused by a variety of, probably partly unknown, etiologies. Effective management of FACP can be challenging owing to the lack of usable diagnostic tools and the availability of a diverse range of treatment approaches. Practical guidance for their selection and use is limited. The objective of this article is to present a working definition of FACP based on expert consensus, and to propose practical strategies for the diagnosis and management of this condition for physicians, pharmacists, and patients. A panel of experts on functional gastrointestinal disorders was convened to participate in workshop activities aimed at defining FACP and agreeing upon a recommended sequence of diagnostic criteria and management recommendations. The key principles forming the foundation of the definition of FACP and suggested management algorithms include the primacy of cramping pain as the distinguishing symptom; the importance of recognizing and acting upon alarm signals of potential structural disease; the recognition of known causes that might be addressed through lifestyle adjustment; and the central role of antispasmodics in the treatment of FACP. The proposed algorithm is intended to assist physicians in reaching a meaningful diagnostic endpoint based on patient-reported symptoms of FACP. We also discuss how this algorithm may be adapted for use by pharmacists and patients.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36149666      PMCID: PMC9553264          DOI: 10.1097/MCG.0000000000001764

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.174


  61 in total

1.  Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.

Authors:  A Madisch; G Holtmann; K Plein; J Hotz
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171

Review 2.  Dependence and addiction during chronic opioid therapy.

Authors:  David N Juurlink; Irfan A Dhalla
Journal:  J Med Toxicol       Date:  2012-12

3.  Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic.

Authors:  Uday N Shivaji; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2014-01-21

4.  Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome.

Authors:  R W Chapman; V Stanghellini; M Geraint; M Halphen
Journal:  Am J Gastroenterol       Date:  2013-07-09       Impact factor: 10.864

5.  The Epidemiology and Quality of Life of Functional Gastrointestinal Disorders According to Rome III vs Rome IV Criteria: A Cross-sectional Study in Primary Care.

Authors:  Kee-Huat Chuah; Keng-Hau Beh; Nurul Azmi Mahammad Rappek; Sanjiv Mahadeva
Journal:  J Dig Dis       Date:  2021-02-17       Impact factor: 2.325

Review 6.  A role for corticotropin-releasing factor in functional gastrointestinal disorders.

Authors:  Yvette Taché; Cornelia Kiank; Andreas Stengel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

7.  On-demand hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain.

Authors:  Brian E Lacy; Fei Wang; Sujata Bhowal; Eckhard Schaefer
Journal:  Scand J Gastroenterol       Date:  2013-08       Impact factor: 2.423

8.  Drug treatment of chronic-intermittent abdominal cramping and pain: a multi-national survey on usage and attitudes.

Authors:  S Mueller-Lissner; E M M Quigley; I Helfrich; E Schaefer
Journal:  Aliment Pharmacol Ther       Date:  2010-05-22       Impact factor: 8.171

Review 9.  Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.

Authors:  Guido N Tytgat
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  What Is New in Rome IV.

Authors:  Max J Schmulson; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.